-
公开(公告)号：US12065488B2
公开(公告)日：2024-08-20
申请号：US17516082
申请日：2021-11-01
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
-
公开(公告)号：US11180549B2
公开(公告)日：2021-11-23
申请号：US16717594
申请日：2019-12-17
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
-
Patent Agency Ranking
公开(公告)号：US20160222104A1
公开(公告)日：2016-08-04
申请号：US15132851
申请日：2016-04-19
Applicant: Janssen Biotech, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: C07K16/24
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2316/96 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.
Abstract translation: 包含具有液体制剂的抗IL-6抗体的笔式注射器装置在诊断和/或治疗组合物，方法和装置中具有应用。
-
公开(公告)号：US20140099311A1
公开(公告)日：2014-04-10
申请号：US14096596
申请日：2013-12-04
Applicant: Applied Molecular Evolution, Inc. , Janssen Biotech, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-Yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan H. Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: C07K16/24
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2316/96 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
Abstract translation: 抗IL-6抗体，包括编码至少一种抗IL-6抗体，载体，宿主细胞，转基因动物或植物的分离的核酸及其制备和使用的方法具有在诊断和/或治疗组合物中的应用 ，方法和设备。
-
公开(公告)号：US09631016B2
公开(公告)日：2017-04-25
申请号：US15132851
申请日：2016-04-19
Applicant: Janssen Biotech, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: A61K39/395 , C07K16/24 , A61K39/00
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2316/96 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: A pen-injector device comprising an anti-IL-6 antibody with a liquid formulation have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号：US09340613B2
公开(公告)日：2016-05-17
申请号：US14096596
申请日：2013-12-04
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xiao-yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: C07K16/24 , A61K39/395 , A61K39/00
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2316/96 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: An anti-IL-6 antibody, including isolated nucleic acids that encode at least one anti-IL-6 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices.
-
公开(公告)号：US20170253651A1
公开(公告)日：2017-09-07
申请号：US15461886
申请日：2017-03-17
Applicant: Janssen Biotech, Inc. , Applied Molecular Evolution, Inc.
Inventor： Yan Chen , Debra Gardner , David M. Knight , Michael W. Lark , Bailin Liang , David M. Marquis , David J. Shealy , Eric Michael Smith , Xioa-yu R. Song , Vedrana Stojanovic-Susulic , Raymond W. Sweet , Susan Tam , Alain P. Vasserot , Sheng-Jiun Wu , Jing Yang
IPC: A61K39/395
CPC classification number: C07K16/248 , A61K2039/505 , A61K2039/54 , C07K2317/21 , C07K2317/24 , C07K2317/33 , C07K2317/34 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/73 , C07K2317/76 , C07K2317/92
Abstract: Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.
-
-
-
-
-
-
Search Results
7
records
(took 0.024 seconds)
